The cognitive effects of electroconvulsive therapy: A critical review

Caterina Mosti*, Michael Brook

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

In this article, we discuss the neurocognitive domains affected by electroconvulsive therapy (ECT), moderators of ECT-related cognitive change, and cognitive outcomes in high-risk populations, as well as compare the cognitive effects ECT to other common treatments for refractory depression. Despite ECT being one of the oldest and most common treatments for refractory depression, various approaches to ECT (ie, strength, wavelength, and electrode placement), use of clinical convenience samples, and employment of varied and often inadequate methods of neurocognitive assessment have contributed to ongoing confusion regarding the nature and severity of post-treatment cognitive side effects. Although findings suggest that most healthy adults return to neurocognitive baseline within a few days after treatment, older adults and those with premorbid neurological impairment may be at an increased risk of prolonged mental status changes post-ECT. Employment of comprehensive neuropsychological batteries versus screening measures may assist in further understanding the nature and course of post-treatment cognitive side effects.

Original languageEnglish (US)
Pages (from-to)152-156
Number of pages5
JournalPsychiatric Annals
Volume49
Issue number4
DOIs
StatePublished - Apr 1 2019

Fingerprint

Electroconvulsive Therapy
Treatment-Resistant Depressive Disorder
Therapeutics
Electrodes
Population

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

@article{12cfa06b4cc64cd195377479d470570c,
title = "The cognitive effects of electroconvulsive therapy: A critical review",
abstract = "In this article, we discuss the neurocognitive domains affected by electroconvulsive therapy (ECT), moderators of ECT-related cognitive change, and cognitive outcomes in high-risk populations, as well as compare the cognitive effects ECT to other common treatments for refractory depression. Despite ECT being one of the oldest and most common treatments for refractory depression, various approaches to ECT (ie, strength, wavelength, and electrode placement), use of clinical convenience samples, and employment of varied and often inadequate methods of neurocognitive assessment have contributed to ongoing confusion regarding the nature and severity of post-treatment cognitive side effects. Although findings suggest that most healthy adults return to neurocognitive baseline within a few days after treatment, older adults and those with premorbid neurological impairment may be at an increased risk of prolonged mental status changes post-ECT. Employment of comprehensive neuropsychological batteries versus screening measures may assist in further understanding the nature and course of post-treatment cognitive side effects.",
author = "Caterina Mosti and Michael Brook",
year = "2019",
month = "4",
day = "1",
doi = "10.3928/00485713-20190313-02",
language = "English (US)",
volume = "49",
pages = "152--156",
journal = "Psychiatric Annals",
issn = "0048-5713",
publisher = "Slack Incorporated",
number = "4",

}

The cognitive effects of electroconvulsive therapy : A critical review. / Mosti, Caterina; Brook, Michael.

In: Psychiatric Annals, Vol. 49, No. 4, 01.04.2019, p. 152-156.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The cognitive effects of electroconvulsive therapy

T2 - A critical review

AU - Mosti, Caterina

AU - Brook, Michael

PY - 2019/4/1

Y1 - 2019/4/1

N2 - In this article, we discuss the neurocognitive domains affected by electroconvulsive therapy (ECT), moderators of ECT-related cognitive change, and cognitive outcomes in high-risk populations, as well as compare the cognitive effects ECT to other common treatments for refractory depression. Despite ECT being one of the oldest and most common treatments for refractory depression, various approaches to ECT (ie, strength, wavelength, and electrode placement), use of clinical convenience samples, and employment of varied and often inadequate methods of neurocognitive assessment have contributed to ongoing confusion regarding the nature and severity of post-treatment cognitive side effects. Although findings suggest that most healthy adults return to neurocognitive baseline within a few days after treatment, older adults and those with premorbid neurological impairment may be at an increased risk of prolonged mental status changes post-ECT. Employment of comprehensive neuropsychological batteries versus screening measures may assist in further understanding the nature and course of post-treatment cognitive side effects.

AB - In this article, we discuss the neurocognitive domains affected by electroconvulsive therapy (ECT), moderators of ECT-related cognitive change, and cognitive outcomes in high-risk populations, as well as compare the cognitive effects ECT to other common treatments for refractory depression. Despite ECT being one of the oldest and most common treatments for refractory depression, various approaches to ECT (ie, strength, wavelength, and electrode placement), use of clinical convenience samples, and employment of varied and often inadequate methods of neurocognitive assessment have contributed to ongoing confusion regarding the nature and severity of post-treatment cognitive side effects. Although findings suggest that most healthy adults return to neurocognitive baseline within a few days after treatment, older adults and those with premorbid neurological impairment may be at an increased risk of prolonged mental status changes post-ECT. Employment of comprehensive neuropsychological batteries versus screening measures may assist in further understanding the nature and course of post-treatment cognitive side effects.

UR - http://www.scopus.com/inward/record.url?scp=85065959987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065959987&partnerID=8YFLogxK

U2 - 10.3928/00485713-20190313-02

DO - 10.3928/00485713-20190313-02

M3 - Article

AN - SCOPUS:85065959987

VL - 49

SP - 152

EP - 156

JO - Psychiatric Annals

JF - Psychiatric Annals

SN - 0048-5713

IS - 4

ER -